Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steven

Showing results (411-420 of 440) with videos related to

Pageof 44
Sort By:
Mbio|August 15, 2019
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid MyelitisNischay Mishra, Terry Fei Fan Ng, Rachel L Marine, et al.
The Journal of Infectious Diseases|October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical TrialsChristopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Journal of the Pediatric Infectious Diseases Society|September 6, 2018
Viral Etiology of Acute Gastroenteritis in <2-Year-Old US Children in the Post-Rotavirus Vaccine EraFerdaus Hassan, Neena Kanwar, Christopher J Harrison, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
NPJ Vaccines|February 12, 2022
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in childrenRahnuma Wahid, Laina Mercer, Chris Gast, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trialsIlse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorJennifer C C Hu, Robert S Coffin, Ceri J Davis, et al.
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
Science (New York, N.Y.)|March 16, 2002
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirusOlen Kew, Victoria Morris-Glasgow, Mauricio Landaverde, et al.
Lancet (London, England)|June 9, 2019
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 studyPierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Pageof 44

Showing results (411-420 of 440) with videos related to

Sort By:
Pageof 44
Mbio|August 15, 2019
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid MyelitisNischay Mishra, Terry Fei Fan Ng, Rachel L Marine, et al.
The Journal of Infectious Diseases|October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical TrialsChristopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Journal of the Pediatric Infectious Diseases Society|September 6, 2018
Viral Etiology of Acute Gastroenteritis in <2-Year-Old US Children in the Post-Rotavirus Vaccine EraFerdaus Hassan, Neena Kanwar, Christopher J Harrison, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
NPJ Vaccines|February 12, 2022
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in childrenRahnuma Wahid, Laina Mercer, Chris Gast, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trialsIlse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorJennifer C C Hu, Robert S Coffin, Ceri J Davis, et al.
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
Science (New York, N.Y.)|March 16, 2002
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirusOlen Kew, Victoria Morris-Glasgow, Mauricio Landaverde, et al.
Lancet (London, England)|June 9, 2019
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 studyPierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Pageof 44